Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Gamete Preservation Market by Donor Type (Known Donor,Anonymous Donor,Others), by Insemination Method (Artificial Insemination,In-vitro Fertilization), by Services Type (Gamete Storage,Gamete Analysis,Genetic Consultation,Specimen Storage,Donor Screening), by End User (Pre-Vasectomy Patients,Police Officers,High-impact Athletes,Cancer Patients,Military Personnel,Transgender People): Global Report opportunity Analysis and Industry Forecast, 2023-2033

A11933

Pages: NA

Charts: NA

Tables: NA

Gamete preservation is a technique to store and preserve gametes such as spermatozoa and oocyte for some time span to use it in the future. The gamete preservation banks are responsible for the storing and freezing of human gametes. The technique of gamete preservation is preferred by men just as women with a probability of losing fertility, due to threat or during clinical treatment of infertility. Gamete preservation banks take and store a huge part of spermatozoa and oocyte for the ones who cannot conceive. Stored gamete cells are utilized by couples for infertility treatments such as in-vitro fertilization or assisted reproductive technology (ART). Improvements in cryopreservation techniques, rise in concern about infertility issue, the emergence of fertility tourism, increase in incidence of miscarriages, escalation in the rate of obesity, and surge in awareness toward infertility treatment are the key factors that drive the growth of the global gamete preservation market.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Increase has been witnessed in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment, including masks, gloves, and protective eyeglasses. The need for medical supplies has increased among both healthcare professionals and civil population for precautionary measures, owing to rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the gamete preservation market.

Top Impacting Factors

  • Exponential rise in the number of male & female infertility, surge in prevalence of obesity, increase in acceptance of gamete preservation services, government activities in assisted reproductive techniques (ART), and alarming upsurge in prevalence of miscarriage acts as the key drivers of the global gamete preservation market.
  • In addition, increase in addiction to smoking, changes in lifestyle, hereditary variables, contact with specific synthetic substances & poisons, issues with sperm & egg formation are affecting fertility in females & males, which, in turn, is projected to contribute toward the market development.
  • Furthermore, developing recognition of lesbian, gay, bisexual, and transgender(LGBT) community is one of the variables that is boosting gamete donations across different nations.
  • An increase in reassuring and financially supporting government activities to put forward better reimbursement situations over various countries are expected to support the uptake of fertility treatments, thus encouraging market growth for gamete preservation.
  • Contrarily, a negative mentality toward gamete banks for pregnancy, high cost of assistive reproduction & artificial insemination, and restricted spread of this technique across the different locales of the world limit the market growth. Moreover, implementation pf different government guidelines for the storage of gamete samples is expected to hamper the market.

Market Trends

Strategies to flourish the market

Different organizations are focusing on organic development policies, for example, product approvals, product launches, and others such as events and patents. Inorganic development policies utilization noticed in the market were acquisitions, and collaborations, and partnerships. These activities have cleared the route for the development of the business and client base of market players.

In April 2019, A majority stake has been acquired by Axcel in European Sperm Bank, which is a leading sperm bank in Europe. This was to expand an existing business and provide effective sperm bank services. Such acquisition will allow the expansion of gametes banks globally during the forecast period.

Funding with the assistance that is provided by government as well as nongovernment groups such as WHO boost the market growth. Furthermore, increase in advanced research activities for the discovery and development of novel technologies would be a major benefit for global players. In addition, rise in reimbursements for gamete donation is fueling the growth of the market.

Key Benefits of the Report

  • This study presents the analytical depiction of the gamete preservation industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years

Questions Answered in the Gamete Preservation Report

  • Which are the leading players active in the gamete preservation market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "gamete preservation"?
  • What is "gamete preservation" market prediction in the future?
  • Who are the leading global players in the "gamete preservation" market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "gamete preservation" market report?  

Key Market Segments

  • By Donor Type
    • Known Donor
    • Anonymous Donor
    • Others
  • By Insemination Method
    • Artificial Insemination
    • In-vitro Fertilization
  • By Services Type
    • Gamete Storage
    • Gamete Analysis
    • Genetic Consultation
    • Specimen Storage
    • Donor Screening
  • By End User
    • Pre-Vasectomy Patients
    • Police Officers
    • High-impact Athletes
    • Cancer Patients
    • Military Personnel
    • Transgender People
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • RepoTech Limited
  • Androcryos
  • European Sperm Bank Aps
  • Fairfax Cryobank Inc.
  • Seattle Sperm Bank
  • Company 10
  • Xytex Corporation
  • Cryos International Aps
  • Indian Spermtech
  • London Sperm Bank Ltd.
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: GAMETE PRESERVATION MARKET, BY DONOR TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Donor Type

    • 4.2. Known Donor

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Anonymous Donor

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Others

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: GAMETE PRESERVATION MARKET, BY INSEMINATION METHOD

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Insemination Method

    • 5.2. Artificial Insemination

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. In-vitro Fertilization

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: GAMETE PRESERVATION MARKET, BY SERVICES TYPE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Services Type

    • 6.2. Gamete Storage

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Gamete Analysis

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Genetic Consultation

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Specimen Storage

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Donor Screening

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: GAMETE PRESERVATION MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Pre-Vasectomy Patients

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Police Officers

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. High-impact Athletes

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Cancer Patients

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

    • 7.6. Military Personnel

      • 7.6.1. Key Market Trends, Growth Factors and Opportunities

      • 7.6.2. Market Size and Forecast, By Region

      • 7.6.3. Market Share Analysis, By Country

    • 7.7. Transgender People

      • 7.7.1. Key Market Trends, Growth Factors and Opportunities

      • 7.7.2. Market Size and Forecast, By Region

      • 7.7.3. Market Share Analysis, By Country

  • CHAPTER 8: GAMETE PRESERVATION MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Donor Type

      • 8.2.3. Market Size and Forecast, By Insemination Method

      • 8.2.4. Market Size and Forecast, By Services Type

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Gamete Preservation Market

        • 8.2.7.1. Market Size and Forecast, By Donor Type
        • 8.2.7.2. Market Size and Forecast, By Insemination Method
        • 8.2.7.3. Market Size and Forecast, By Services Type
        • 8.2.7.4. Market Size and Forecast, By End User
      • 8.2.8. Canada Gamete Preservation Market

        • 8.2.8.1. Market Size and Forecast, By Donor Type
        • 8.2.8.2. Market Size and Forecast, By Insemination Method
        • 8.2.8.3. Market Size and Forecast, By Services Type
        • 8.2.8.4. Market Size and Forecast, By End User
      • 8.2.9. Mexico Gamete Preservation Market

        • 8.2.9.1. Market Size and Forecast, By Donor Type
        • 8.2.9.2. Market Size and Forecast, By Insemination Method
        • 8.2.9.3. Market Size and Forecast, By Services Type
        • 8.2.9.4. Market Size and Forecast, By End User
    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Donor Type

      • 8.3.3. Market Size and Forecast, By Insemination Method

      • 8.3.4. Market Size and Forecast, By Services Type

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Gamete Preservation Market

        • 8.3.7.1. Market Size and Forecast, By Donor Type
        • 8.3.7.2. Market Size and Forecast, By Insemination Method
        • 8.3.7.3. Market Size and Forecast, By Services Type
        • 8.3.7.4. Market Size and Forecast, By End User
      • 8.3.8. Germany Gamete Preservation Market

        • 8.3.8.1. Market Size and Forecast, By Donor Type
        • 8.3.8.2. Market Size and Forecast, By Insemination Method
        • 8.3.8.3. Market Size and Forecast, By Services Type
        • 8.3.8.4. Market Size and Forecast, By End User
      • 8.3.9. Italy Gamete Preservation Market

        • 8.3.9.1. Market Size and Forecast, By Donor Type
        • 8.3.9.2. Market Size and Forecast, By Insemination Method
        • 8.3.9.3. Market Size and Forecast, By Services Type
        • 8.3.9.4. Market Size and Forecast, By End User
      • 8.3.10. Spain Gamete Preservation Market

        • 8.3.10.1. Market Size and Forecast, By Donor Type
        • 8.3.10.2. Market Size and Forecast, By Insemination Method
        • 8.3.10.3. Market Size and Forecast, By Services Type
        • 8.3.10.4. Market Size and Forecast, By End User
      • 8.3.11. UK Gamete Preservation Market

        • 8.3.11.1. Market Size and Forecast, By Donor Type
        • 8.3.11.2. Market Size and Forecast, By Insemination Method
        • 8.3.11.3. Market Size and Forecast, By Services Type
        • 8.3.11.4. Market Size and Forecast, By End User
      • 8.3.12. Russia Gamete Preservation Market

        • 8.3.12.1. Market Size and Forecast, By Donor Type
        • 8.3.12.2. Market Size and Forecast, By Insemination Method
        • 8.3.12.3. Market Size and Forecast, By Services Type
        • 8.3.12.4. Market Size and Forecast, By End User
      • 8.3.13. Rest Of Europe Gamete Preservation Market

        • 8.3.13.1. Market Size and Forecast, By Donor Type
        • 8.3.13.2. Market Size and Forecast, By Insemination Method
        • 8.3.13.3. Market Size and Forecast, By Services Type
        • 8.3.13.4. Market Size and Forecast, By End User
    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Donor Type

      • 8.4.3. Market Size and Forecast, By Insemination Method

      • 8.4.4. Market Size and Forecast, By Services Type

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Gamete Preservation Market

        • 8.4.7.1. Market Size and Forecast, By Donor Type
        • 8.4.7.2. Market Size and Forecast, By Insemination Method
        • 8.4.7.3. Market Size and Forecast, By Services Type
        • 8.4.7.4. Market Size and Forecast, By End User
      • 8.4.8. Japan Gamete Preservation Market

        • 8.4.8.1. Market Size and Forecast, By Donor Type
        • 8.4.8.2. Market Size and Forecast, By Insemination Method
        • 8.4.8.3. Market Size and Forecast, By Services Type
        • 8.4.8.4. Market Size and Forecast, By End User
      • 8.4.9. India Gamete Preservation Market

        • 8.4.9.1. Market Size and Forecast, By Donor Type
        • 8.4.9.2. Market Size and Forecast, By Insemination Method
        • 8.4.9.3. Market Size and Forecast, By Services Type
        • 8.4.9.4. Market Size and Forecast, By End User
      • 8.4.10. South Korea Gamete Preservation Market

        • 8.4.10.1. Market Size and Forecast, By Donor Type
        • 8.4.10.2. Market Size and Forecast, By Insemination Method
        • 8.4.10.3. Market Size and Forecast, By Services Type
        • 8.4.10.4. Market Size and Forecast, By End User
      • 8.4.11. Australia Gamete Preservation Market

        • 8.4.11.1. Market Size and Forecast, By Donor Type
        • 8.4.11.2. Market Size and Forecast, By Insemination Method
        • 8.4.11.3. Market Size and Forecast, By Services Type
        • 8.4.11.4. Market Size and Forecast, By End User
      • 8.4.12. Thailand Gamete Preservation Market

        • 8.4.12.1. Market Size and Forecast, By Donor Type
        • 8.4.12.2. Market Size and Forecast, By Insemination Method
        • 8.4.12.3. Market Size and Forecast, By Services Type
        • 8.4.12.4. Market Size and Forecast, By End User
      • 8.4.13. Malaysia Gamete Preservation Market

        • 8.4.13.1. Market Size and Forecast, By Donor Type
        • 8.4.13.2. Market Size and Forecast, By Insemination Method
        • 8.4.13.3. Market Size and Forecast, By Services Type
        • 8.4.13.4. Market Size and Forecast, By End User
      • 8.4.14. Indonesia Gamete Preservation Market

        • 8.4.14.1. Market Size and Forecast, By Donor Type
        • 8.4.14.2. Market Size and Forecast, By Insemination Method
        • 8.4.14.3. Market Size and Forecast, By Services Type
        • 8.4.14.4. Market Size and Forecast, By End User
      • 8.4.15. Rest of Asia Pacific Gamete Preservation Market

        • 8.4.15.1. Market Size and Forecast, By Donor Type
        • 8.4.15.2. Market Size and Forecast, By Insemination Method
        • 8.4.15.3. Market Size and Forecast, By Services Type
        • 8.4.15.4. Market Size and Forecast, By End User
    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Donor Type

      • 8.5.3. Market Size and Forecast, By Insemination Method

      • 8.5.4. Market Size and Forecast, By Services Type

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Gamete Preservation Market

        • 8.5.7.1. Market Size and Forecast, By Donor Type
        • 8.5.7.2. Market Size and Forecast, By Insemination Method
        • 8.5.7.3. Market Size and Forecast, By Services Type
        • 8.5.7.4. Market Size and Forecast, By End User
      • 8.5.8. South Africa Gamete Preservation Market

        • 8.5.8.1. Market Size and Forecast, By Donor Type
        • 8.5.8.2. Market Size and Forecast, By Insemination Method
        • 8.5.8.3. Market Size and Forecast, By Services Type
        • 8.5.8.4. Market Size and Forecast, By End User
      • 8.5.9. Saudi Arabia Gamete Preservation Market

        • 8.5.9.1. Market Size and Forecast, By Donor Type
        • 8.5.9.2. Market Size and Forecast, By Insemination Method
        • 8.5.9.3. Market Size and Forecast, By Services Type
        • 8.5.9.4. Market Size and Forecast, By End User
      • 8.5.10. UAE Gamete Preservation Market

        • 8.5.10.1. Market Size and Forecast, By Donor Type
        • 8.5.10.2. Market Size and Forecast, By Insemination Method
        • 8.5.10.3. Market Size and Forecast, By Services Type
        • 8.5.10.4. Market Size and Forecast, By End User
      • 8.5.11. Argentina Gamete Preservation Market

        • 8.5.11.1. Market Size and Forecast, By Donor Type
        • 8.5.11.2. Market Size and Forecast, By Insemination Method
        • 8.5.11.3. Market Size and Forecast, By Services Type
        • 8.5.11.4. Market Size and Forecast, By End User
      • 8.5.12. Rest of LAMEA Gamete Preservation Market

        • 8.5.12.1. Market Size and Forecast, By Donor Type
        • 8.5.12.2. Market Size and Forecast, By Insemination Method
        • 8.5.12.3. Market Size and Forecast, By Services Type
        • 8.5.12.4. Market Size and Forecast, By End User
  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning, 2024

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Androcryos

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. London Sperm Bank Ltd.

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. RepoTech Limited

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Cryos International Aps

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Fairfax Cryobank Inc.

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Indian Spermtech

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. European Sperm Bank Aps

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Xytex Corporation

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Seattle Sperm Bank

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Company 10

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL GAMETE PRESERVATION MARKET, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL GAMETE PRESERVATION MARKET FOR KNOWN DONOR, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL GAMETE PRESERVATION MARKET FOR ANONYMOUS DONOR, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL GAMETE PRESERVATION MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL GAMETE PRESERVATION MARKET, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL GAMETE PRESERVATION MARKET FOR ARTIFICIAL INSEMINATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL GAMETE PRESERVATION MARKET FOR IN-VITRO FERTILIZATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL GAMETE PRESERVATION MARKET, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL GAMETE PRESERVATION MARKET FOR GAMETE STORAGE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL GAMETE PRESERVATION MARKET FOR GAMETE ANALYSIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL GAMETE PRESERVATION MARKET FOR GENETIC CONSULTATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL GAMETE PRESERVATION MARKET FOR SPECIMEN STORAGE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL GAMETE PRESERVATION MARKET FOR DONOR SCREENING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL GAMETE PRESERVATION MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL GAMETE PRESERVATION MARKET FOR PRE-VASECTOMY PATIENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL GAMETE PRESERVATION MARKET FOR POLICE OFFICERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL GAMETE PRESERVATION MARKET FOR HIGH-IMPACT ATHLETES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL GAMETE PRESERVATION MARKET FOR CANCER PATIENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. GLOBAL GAMETE PRESERVATION MARKET FOR MILITARY PERSONNEL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. GLOBAL GAMETE PRESERVATION MARKET FOR TRANSGENDER PEOPLE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. GLOBAL GAMETE PRESERVATION MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 22. NORTH AMERICA GAMETE PRESERVATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 23. NORTH AMERICA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 24. NORTH AMERICA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 25. NORTH AMERICA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 26. NORTH AMERICA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. U.S. GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 28. U.S. GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 29. U.S. GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 30. U.S. GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. CANADA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 32. CANADA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 33. CANADA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 34. CANADA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. MEXICO GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 36. MEXICO GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 37. MEXICO GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 38. MEXICO GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. EUROPE GAMETE PRESERVATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 40. EUROPE GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 41. EUROPE GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 42. EUROPE GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 43. EUROPE GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. FRANCE GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 45. FRANCE GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 46. FRANCE GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 47. FRANCE GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. GERMANY GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 49. GERMANY GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 50. GERMANY GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 51. GERMANY GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. ITALY GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 53. ITALY GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 54. ITALY GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 55. ITALY GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. SPAIN GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 57. SPAIN GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 58. SPAIN GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 59. SPAIN GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 60. UK GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 61. UK GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 62. UK GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 63. UK GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. RUSSIA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 65. RUSSIA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 66. RUSSIA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 67. RUSSIA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. REST OF EUROPE GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 69. REST OF EUROPE GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 70. REST OF EUROPE GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 71. REST OF EUROPE GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. ASIA-PACIFIC GAMETE PRESERVATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 73. ASIA-PACIFIC GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 74. ASIA-PACIFIC GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 75. ASIA-PACIFIC GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 76. ASIA-PACIFIC GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 77. CHINA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 78. CHINA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 79. CHINA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 80. CHINA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 81. JAPAN GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 82. JAPAN GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 83. JAPAN GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 84. JAPAN GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 85. INDIA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 86. INDIA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 87. INDIA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 88. INDIA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 89. SOUTH KOREA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH KOREA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH KOREA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH KOREA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 93. AUSTRALIA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 94. AUSTRALIA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 95. AUSTRALIA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 96. AUSTRALIA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 97. THAILAND GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 98. THAILAND GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 99. THAILAND GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 100. THAILAND GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 101. MALAYSIA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 102. MALAYSIA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 103. MALAYSIA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 104. MALAYSIA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 105. INDONESIA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 106. INDONESIA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 107. INDONESIA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 108. INDONESIA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 112. REST OF ASIA PACIFIC GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 113. LAMEA GAMETE PRESERVATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 114. LAMEA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 115. LAMEA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 116. LAMEA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 117. LAMEA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 118. BRAZIL GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 119. BRAZIL GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 120. BRAZIL GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 121. BRAZIL GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 122. SOUTH AFRICA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 123. SOUTH AFRICA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 124. SOUTH AFRICA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 125. SOUTH AFRICA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 126. SAUDI ARABIA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 127. SAUDI ARABIA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 128. SAUDI ARABIA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 129. SAUDI ARABIA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 130. UAE GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 131. UAE GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 132. UAE GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 133. UAE GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 134. ARGENTINA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 135. ARGENTINA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 136. ARGENTINA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 137. ARGENTINA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 138. REST OF LAMEA GAMETE PRESERVATION, BY DONOR TYPE, 2025-2033 ($MILLION)
  • TABLE 139. REST OF LAMEA GAMETE PRESERVATION, BY INSEMINATION METHOD, 2025-2033 ($MILLION)
  • TABLE 140. REST OF LAMEA GAMETE PRESERVATION, BY SERVICES TYPE, 2025-2033 ($MILLION)
  • TABLE 141. REST OF LAMEA GAMETE PRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 142. ANDROCRYOS: KEY EXECUTIVES
  • TABLE 143. ANDROCRYOS: COMPANY SNAPSHOT
  • TABLE 144. ANDROCRYOS: OPERATING SEGMENTS
  • TABLE 145. ANDROCRYOS: PRODUCT PORTFOLIO
  • TABLE 146. ANDROCRYOS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. LONDON SPERM BANK LTD.: KEY EXECUTIVES
  • TABLE 148. LONDON SPERM BANK LTD.: COMPANY SNAPSHOT
  • TABLE 149. LONDON SPERM BANK LTD.: OPERATING SEGMENTS
  • TABLE 150. LONDON SPERM BANK LTD.: PRODUCT PORTFOLIO
  • TABLE 151. LONDON SPERM BANK LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. REPOTECH LIMITED: KEY EXECUTIVES
  • TABLE 153. REPOTECH LIMITED: COMPANY SNAPSHOT
  • TABLE 154. REPOTECH LIMITED: OPERATING SEGMENTS
  • TABLE 155. REPOTECH LIMITED: PRODUCT PORTFOLIO
  • TABLE 156. REPOTECH LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. CRYOS INTERNATIONAL APS: KEY EXECUTIVES
  • TABLE 158. CRYOS INTERNATIONAL APS: COMPANY SNAPSHOT
  • TABLE 159. CRYOS INTERNATIONAL APS: OPERATING SEGMENTS
  • TABLE 160. CRYOS INTERNATIONAL APS: PRODUCT PORTFOLIO
  • TABLE 161. CRYOS INTERNATIONAL APS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 162. FAIRFAX CRYOBANK INC.: KEY EXECUTIVES
  • TABLE 163. FAIRFAX CRYOBANK INC.: COMPANY SNAPSHOT
  • TABLE 164. FAIRFAX CRYOBANK INC.: OPERATING SEGMENTS
  • TABLE 165. FAIRFAX CRYOBANK INC.: PRODUCT PORTFOLIO
  • TABLE 166. FAIRFAX CRYOBANK INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 167. INDIAN SPERMTECH: KEY EXECUTIVES
  • TABLE 168. INDIAN SPERMTECH: COMPANY SNAPSHOT
  • TABLE 169. INDIAN SPERMTECH: OPERATING SEGMENTS
  • TABLE 170. INDIAN SPERMTECH: PRODUCT PORTFOLIO
  • TABLE 171. INDIAN SPERMTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 172. EUROPEAN SPERM BANK APS: KEY EXECUTIVES
  • TABLE 173. EUROPEAN SPERM BANK APS: COMPANY SNAPSHOT
  • TABLE 174. EUROPEAN SPERM BANK APS: OPERATING SEGMENTS
  • TABLE 175. EUROPEAN SPERM BANK APS: PRODUCT PORTFOLIO
  • TABLE 176. EUROPEAN SPERM BANK APS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 177. XYTEX CORPORATION: KEY EXECUTIVES
  • TABLE 178. XYTEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 179. XYTEX CORPORATION: OPERATING SEGMENTS
  • TABLE 180. XYTEX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 181. XYTEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 182. SEATTLE SPERM BANK: KEY EXECUTIVES
  • TABLE 183. SEATTLE SPERM BANK: COMPANY SNAPSHOT
  • TABLE 184. SEATTLE SPERM BANK: OPERATING SEGMENTS
  • TABLE 185. SEATTLE SPERM BANK: PRODUCT PORTFOLIO
  • TABLE 186. SEATTLE SPERM BANK: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 187. COMPANY 10: KEY EXECUTIVES
  • TABLE 188. COMPANY 10: COMPANY SNAPSHOT
  • TABLE 189. COMPANY 10: OPERATING SEGMENTS
  • TABLE 190. COMPANY 10: PRODUCT PORTFOLIO
  • TABLE 191. COMPANY 10: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL GAMETE PRESERVATION MARKET SEGMENTATION
  • FIGURE 2. GLOBAL GAMETE PRESERVATION MARKET
  • FIGURE 3. SEGMENTATION GAMETE PRESERVATION MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN GAMETE PRESERVATION MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALGAMETE PRESERVATION MARKET
  • FIGURE 11. GAMETE PRESERVATION MARKET SEGMENTATION, BY BY DONOR TYPE
  • FIGURE 12. GAMETE PRESERVATION MARKET FOR KNOWN DONOR, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. GAMETE PRESERVATION MARKET FOR ANONYMOUS DONOR, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. GAMETE PRESERVATION MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. GAMETE PRESERVATION MARKET SEGMENTATION, BY BY INSEMINATION METHOD
  • FIGURE 16. GAMETE PRESERVATION MARKET FOR ARTIFICIAL INSEMINATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. GAMETE PRESERVATION MARKET FOR IN-VITRO FERTILIZATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. GAMETE PRESERVATION MARKET SEGMENTATION, BY BY SERVICES TYPE
  • FIGURE 19. GAMETE PRESERVATION MARKET FOR GAMETE STORAGE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. GAMETE PRESERVATION MARKET FOR GAMETE ANALYSIS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. GAMETE PRESERVATION MARKET FOR GENETIC CONSULTATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. GAMETE PRESERVATION MARKET FOR SPECIMEN STORAGE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. GAMETE PRESERVATION MARKET FOR DONOR SCREENING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. GAMETE PRESERVATION MARKET SEGMENTATION, BY BY END USER
  • FIGURE 25. GAMETE PRESERVATION MARKET FOR PRE-VASECTOMY PATIENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. GAMETE PRESERVATION MARKET FOR POLICE OFFICERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. GAMETE PRESERVATION MARKET FOR HIGH-IMPACT ATHLETES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 28. GAMETE PRESERVATION MARKET FOR CANCER PATIENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 29. GAMETE PRESERVATION MARKET FOR MILITARY PERSONNEL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 30. GAMETE PRESERVATION MARKET FOR TRANSGENDER PEOPLE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 31. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 32. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 33. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 34. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 35. COMPETITIVE DASHBOARD
  • FIGURE 36. COMPETITIVE HEATMAP: GAMETE PRESERVATION MARKET
  • FIGURE 37. TOP PLAYER POSITIONING, 2024
  • FIGURE 38. ANDROCRYOS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. ANDROCRYOS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. ANDROCRYOS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. LONDON SPERM BANK LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. LONDON SPERM BANK LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. LONDON SPERM BANK LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. REPOTECH LIMITED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. REPOTECH LIMITED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. REPOTECH LIMITED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. CRYOS INTERNATIONAL APS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. CRYOS INTERNATIONAL APS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. CRYOS INTERNATIONAL APS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. FAIRFAX CRYOBANK INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. FAIRFAX CRYOBANK INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. FAIRFAX CRYOBANK INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. INDIAN SPERMTECH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. INDIAN SPERMTECH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. INDIAN SPERMTECH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. EUROPEAN SPERM BANK APS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. EUROPEAN SPERM BANK APS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. EUROPEAN SPERM BANK APS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. XYTEX CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. XYTEX CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. XYTEX CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 62. SEATTLE SPERM BANK: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 63. SEATTLE SPERM BANK: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 64. SEATTLE SPERM BANK: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 65. COMPANY 10: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 66. COMPANY 10: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 67. COMPANY 10: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Gamete Preservation Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue